Nancy Vitale’s Post

Cheers to the women who continue to break past the cement ceiling during their careers in biopharma. However; shocking trends remain. Its industry-specific analysis showed that while women outnumber men in entry-level roles in the pharmaceuticals and medical products segment, making up 52% of those positions, female representation steadily decreases at every subsequent rung of the job ladder, culminating in just a 28% share of C-suite positions. This is a decline of 33% last year. Even more shocking, according to McKinsey’s latest report, the women who make up 29% of C-suite positions across all industries break down into 22% white women and JUST 7% women of color. I anticipate this decline will worsen within the next 4 years with the war against DEI and the rise of the MAGA movement.

OFF THE RECORD - WOMEN LEADERS IN LIFE SCIENCES Seeing so many women leaders in life sciences research and entrepreneurship. When you read @Nancy Hopkins book “The Exceptions” you realize how much each one of these women have achieved and wonder what obstacles they faced, what stories they have to share. But we can all applaud. #WomenLeadersInLifeSciences #WomenLeaders #LifeSciences #LifeScienceInnovation #TheExceptions

Hear tips for getting your voice heard in the C-suite.

IF YOU BLINKED YOU MISSED IT: FOLLOW UP TO IYBYMI - 7 Check out Fortune Oct/Nov 2023: "The 100 Most Powerful Women". 9 of the most 100 powerful women are in healthcare with Karen Lynch, CEO of CVS Health coming in at No. 1. The list is global in scope. Notable drop: ex-Walgreens CEO Rosaling Brewer, who stepped down in Aug 2023, one of 2 Black female CEOs running Fortune 500 companies; TIAA CEO Thasunda Brown Duckett is now the only exec with that distinction. In the first half 2023, 106 CEOs left their jobs. Of the CEO replacements, 13 percent were women, up from 2.4% in 2018 at No. 7: Emma Walmsley CEO GSK; at No. 10: Gail Boudreaux, Pres/CEO Elevance, nee Anthem; at 27, Heather Cianfrocco Pres.Optum; 29 Angela Hwang Chief Commercial Officer & Pres. at Pfizer; at 30 Belen Garijo Chair & CEO Merck KGaa; at 40 Sarah London with Centene; at 79 Jennifer Taubert, Exec VP & WW Chair Pharmaceutical JNJ; at 91, Rashma Kewalramani Pres & CEO, Vertex. This list will have many more women in 5 years: May 4, 2029. See you then in cyberspace. The article is a must read. Dr. Bill

It's not a new topic, but an important one to keep front and center. Female-founded biotechs received less than $6B out the nearly $30B biopharma VCs distributed last year - with wide ranging ramifications for the health and wellness of half of the global population. And it all starts with who holds the checkbook. More women VCs --> more funding to women led companies + more women on boards + more women on executive teams. More in Endpoints News today. https://lnkd.in/eBJFcuTi

"Such an important statistic to highlight! At ELLKAY, we’re committed to amplifying the voices of these trailblazers through our Women in Health IT series. Check out their inspiring stories and celebrate the impact they’re making in healthcare technology with us. 💻💡 #WomenInHealthIT #HealthcareLeadership"

When I think about International Women’s Day, three words come to mind: FORCE FOR GOOD. And goodness comes from within. I proudly lead an organization at GeneDx comprised of 68% women. And of our senior leadership team, 55% of them are women. I’m a constant witness to the way we work — with courage, resilience, and a deep commitment to our patients — and the way we live outside of work — with big hearts, compassion and a ferocity for doing good in the world. We are indeed doing very hard things in the world of genetics, in the world of healthcare, and in the world of today’s capital markets. And — with the amazing men who are allies to us at work and at home — we are well on our way to making sure we realize our mission of ending the diagnostic odyssey. We are relentless in our pursuit of getting children diagnosed sooner, connecting them to treatments and connecting families and caregivers to advocacy support, all while ensuring our company is financially stronger each day and on the path to profitability. It’s a lot of competing priorities, but we’re doing it, day in and day out. Why? Because we are a FORCE FOR GOOD. That’s all. #internationalwomensday2024

Negative inner chatter vs connecting to a deeper 'inner knowing' This week the Loose Women in Pharma discuss how negative inner chatter can hold us back. Miriam has read (another) book (of course she has!) and Sarah has been out of her comfort zone in a spin class😱. As they adventure into another growth mindset topic, they realise that they both have different ways of quietening negative inner chatter and tapping into a deeper 'sense of knowing', or ‘feeling', which is where we can live our most joyful life and tap into a world of endless possibilities☀️ Women in Pharma (WiP) #beyondbikinimedicine #whatispossible #weinspirepotential

Negative inner chatter vs connecting to a deeper 'inner knowing' This week the Loose Women in Pharma discuss how negative inner chatter can hold us back. Miriam has read (another) book (of course she has!) and Sarah has been out of her comfort zone in a spin class😱. As they adventure into another growth mindset topic, they realise that they both have different ways of quietening negative inner chatter and tapping into a deeper 'sense of knowing', or ‘feeling', which is where we can live our most joyful life and tap into a world of endless possibilities☀️ Women in Pharma (WiP) #beyondbikinimedicine #whatispossible #weinspirepotential

Love to see it! Great read highlighting the progress female investors have made in the biotech industry! It's encouraging to see the push for more women in leadership roles and on boards. Diversity in decision-making is crucial for innovation and long-term success. #WomenInBiotech https://lnkd.in/eRvS79zu